J . Org. Chem. 1999, 64, 23-27
23
Tota l Syn th esis of Myxa la m id e A
Anna K. Mapp and Clayton H. Heathcock*
Department of Chemistry, University of California, Berkeley, California 94720
Received J uly 14, 1998
The polyene antibiotic myxalamide A (1) has been prepared by total synthesis. The synthesis
illustrates a useful strategy for synthesis in which the high 1,2-stereocontrol achievable with the
aldol reaction can be parlayed by other stereoselective processes so as to give compounds having
two or more stereocenters with remote relationships. Application of the Evans asymmetric aldol
reaction to aldehyde 13 gives the â-hydroxy imide 17. Because the substrate is an R,â-unsaturated
aldehyde, the alcohol is allylic. After suitable functional group manipulation, this allylic alcohol
is subjected to enolate Claisen rearrangement (as propionate 22) to give allylsulfide 23, having
three stereocenters with a 1,4,5-relationship. Further functional group manipulation and one-
carbon homologation converts this intermediate into 26, which is oxidized and subjected to Evans-
Mislow allylsulfoxide rearrangement to obtain 27, having three stereocenters with a 1,2,5-
relationship. The synthesis of myxalamide A was completed by converting aldehyde 30 into dienyne
40. Alkyne 40 was hydroborated with catechol borane, and the resulting E-vinylborane was
subjected to Suzuki coupling with the Z-iodo triene 9 to provide myxalamide A (1).
As a result of a great amount of research in the 1970s
and 1980s, the addition of preformed enolates to alde-
hydes to obtain R-substituted-â-hydroxy carbonyl com-
pounds is a well-established synthetic procedure.1 As
part of our own work in this area, we showed that one
can parlay the high 1,2-stereocontrol of the aldol reaction
into relative control of more remote stereocenters. For
example, by carrying out the aldol reaction on an R,â-
unsaturated aldehyde and following with an Ireland ester
enolate Claisen rearrangement, one can achieve 1,4- and
1,5-stereocontrol.2 When the starting aldehyde is a
â-alkylthio-R,â-unsaturated aldehyde, one can couple the
stereocontrolled aldol reaction with an ester enolate
Claisen rearrangement and an Evans-Mislow allylsul-
foxide rearrangement to prepare compounds having three
stereocenters with a 1,2,5-relationship.3 In this article,
heart submitochondrial particles with an IC50 of 170 pm/
mg of protein. The phenalamides were isolated more
recently from Myxococcus stipiatus.5 Phenalamide A1
(stipiamide) (2) exhibits antifungal and antiviral proper-
ties as well as the ability to reverse P-glycoprotein-
mediated multidrug resistance.5,6
The myxalamides and the phenalamides have at-
tracted some synthetic attention. A partial synthesis of
myxalamide D (5) was reported by Cox and Whiting in
which an anti aldol reaction was used to set the C12/
C13 stereochemistry.7 In addition, a total synthesis of
phenalamide A1 (2) was recently described.6 In this
approach, an asymmetric alkylation set the distal ste-
reocenter (C16), while an asymmetric crotylboration
created the anti stereorelationship at C12/C13. In
we report a further application of this strategy for the
total synthesis of myxalamide A (1).
Myxalamide A is one of a growing number of polyene
antibiotics, which includes the phenalamides as well as
the myxalamides. The four myxalamides were isolated
from the gliding bacteria Myxococcus xanthus, and the
most abundant of the group, myxalamide B (3), was found
to be a potent electron-transport inhibitor and exhibited
antibiotic and antifungal activity.4 Myxalamide B was
shown to inhibit NADH oxidation at complex I in beef
(1) Heathcock, C. H. In Asymmetric Synthesis; Morrison, J . D., Ed.;
Academic Press: New York, 1984, Vol. 3.
(2) (a) Heathcock, C. H.; J arvi, E. T. Tetrahedron Lett. 1982, 23,
2825. (b) Heathcock, C. H.; J arvi, E. T.; Rosen, T. Tetrahedron Lett.
1984, 25, 243. (c) Heathcock, C. H.; Finkelstein, B. L. J . Chem. Soc.,
Chem. Commun. 1983, 919. (d) Heathcock, C. H.; Finkelstein, B. L.;
Aoki, T.; Poulter, C. D. Science (Washington, D.C.) 1985, 229, 862. (e)
Heathcock, C. H.; Radel, P. A. J . Org. Chem. 1986, 51, 4323. (f)
Heathcock, C. H.; Finklestein, B. L.; J arvi, E. T.; Radel, P. A.; Hadley,
C. R. J . Org. Chem. 1987, 53, 1922.
(3) Munchhof, M. J .; Heathcock, C. H. J . Org. Chem. 1994, 59, 7566.
(4) (a) J ansen, R.; Reifenstahl, G.; Gerth, K.; Reichenbach, H.; Ho¨fle,
G. Liebigs Ann. Chem. 1983, 1081. (b) Gerth, K.; J ansen, R.; Reifen-
stahl, G.; Ho¨fle, G.; Irschik, H.; Kunze, B.; Reichenbach, H.; Thierbach.
G. J . Antibiot. 1983, 36, 1150. (c) J ansen, R.; Sheldrick, W. S.; Ho¨fle,
G. Liebigs Ann. Chem. 1984, 78.
(5) (a) Kim, Y. J .; Furihata, K.; Yamanaka, S.; Fudo, R.; Seto, H. J .
Antibiot. 1991, 553. (b) Trowitzsch-Kienast, W.; Forche, E.; Wray, V.;
Riechenbach, H.; J unsmann, G.; Ho¨fle, G. Liebigs Ann. Chem. 1992,
659.
(6) (a) Andrus, M. B.; Lepore, S. D. J . Am. Chem. Soc. 1997, 119,
2327. (b) Andrus, M. B.; Lepore, S. D.; Turner, T. M. J . Am. Chem.
Soc. 1997, 119, 12159.
(7) (a) Cox, C. M.; Whiting, D. A. J . Chem. Soc., Perkin Trans. I
1991, 1901. (b) Cox, C. M.; Whiting, D. A. J . Chem. Soc., Perkin Trans.
I, 1991, 1907. (c) Cox, C. M.; Whiting, D. A. J . Chem. Soc., Perkin I,
1991, 660.
10.1021/jo9813742 CCC: $18.00 © 1999 American Chemical Society
Published on Web 12/11/1998